Showing results (2731-2740 of 8,949) with videos related to

Sort By:
Pageof 895
Schizophrenia Research|July 6, 2019
IQ differences between patients with first episode psychosis in London and Palermo reflect differences in patterns of cannabis useLaura Ferraro, Robin M Murray, Marta Di Forti, et al.
Schizophrenia Research|June 6, 2019
Adjunctive memantine for major mental disorders: A systematic review and meta-analysis of randomized double-blind controlled trialsWei Zheng, Xiao-Min Zhu, Qing-E Zhang, et al.
Schizophrenia Research|June 29, 2019
Stress precedes negative symptom exacerbations in clinical high risk and early psychosis: A time-lagged experience sampling studyCory Gerritsen, R Michael Bagby, Marcos Sanches, et al.
Schizophrenia Research|February 19, 2022
Changes in emotion processing and social cognition with auditory versus visual neuroscience-informed cognitive training in individuals with schizophreniaLinda Scoriels, Larissa T Genaro, Stella Keffer, et al.
Schizophrenia Research|February 3, 2022
Impact of coping styles on substance use in persons with psychosis, siblings, and controlsHeleen S van der Heijden, Frederike Schirmbeck, Liza Berry, et al.
Schizophrenia Research|February 18, 2022
Healthcare costs and resource use associated with negative symptoms of schizophrenia: A systematic literature reviewSharon Weber, James G Scott, Mary Lou Chatterton
Schizophrenia Research|February 18, 2022
Increased amplitude of hippocampal low frequency fluctuations in early psychosis: A two-year follow-up studyMaureen McHugo, Baxter P Rogers, Suzanne N Avery, et al.
Schizophrenia Research|February 17, 2022
The neurobiological characterization of distinct cognitive subtypes in early-phase schizophrenia-spectrum disordersP P Oomen, S S Gangadin, M J H Begemann, et al.
Schizophrenia Research|April 9, 2022
The effect on relapse rate and psychiatric symptomatology: Switching a combination of first- and second-generation antipsychotic polypharmacy to antipsychotic monotherapy in long-term inpatients with schizophrenia and related disorders. A pragmatic randomized open-label trial (SwAP trial)Mushde Shakir, Anne E Willems, Peter N van Harten, et al.
Schizophrenia Research|September 23, 2018
A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16 week randomized placebo-controlled trial for participants concurrently treated with risperidoneDelbert G Robinson, Juan A Gallego, Majnu John, et al.
Pageof 895